This is a routine annual meeting filing with no surprises. Monitor for the outcome of the shareholder vote, but expect no immediate market impact.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 24 $12.63entry
- T+1 · 7mo ago +2.61%α +2.45% · $12.96
- T+5 · 7mo ago +6.89%α +5.98% · $13.50
- T+20 · 6mo ago −50.04%α −54.07% · $6.31
- T+60 · 4mo ago −48.85%α −53.93% · $6.46
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Entrada Therapeutics is holding a shareholder meeting to vote on the election of directors, approval of the 2025 annual compensation program, and ratification of auditors. The filing is a definitive additional materials document, which is routine for an annual meeting.
Key Financial Metrics
Key Facts
- Filing is a Definitive Additional Materials (DEFA14A) for an annual shareholder meeting.
- Vote includes election of directors, approval of 2025 annual compensation program, and ratification of auditors.
- No activist campaign or dissident filing; this is a routine management filing.
- Recent insider activity shows minimal selling ($32K over 30 days).
Financial Impact
Minimal to no direct financial impact from this filing.
Risk Factors
- Potential shareholder dissent on executive compensation (though not indicated in this filing).
- Regulatory or compliance risk if auditors are not ratified.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001689375-26-000022 |
| Document: 0001689375-26-000022-index-headers.html | 0001689375-26-000022 |
| Document: 0001689375-26-000022-index.html | 0001689375-26-000022 |
| Document: 0001689375-26-000022.txt | 0001689375-26-000022 |
Track record
21 reports on TRDA
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +58.22% at T+20 after the May 4, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 5, 202611d ago 8-K Neutral 4/10 No price data
- Nov 5, 202611d ago Press Release Neutral 4/10 Entry $4.55 Now $5.00 +9.89% settles Feb 3
- Oct 14, 20264w ago 8-K Bullish 6/10 Entry $4.55 Now $5.00 +9.89% settles Jan 11
- Sep 9, 20269w ago Insider Cluster Bearish 6/10 Entry $6.42 Now $5.00 +22.12% settles Dec 4
- Sep 3, 202610w ago Insider Cluster Neutral 3/10 Entry $7.13 Now $5.00 −29.87% settles Dec 1
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 4/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 31, 202611w ago Insider Cluster Neutral 3/10 Entry $7.07 Now $5.00 −29.28% settles Nov 25
- Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $7.27 Now $5.00 −31.22% settles Nov 20
- Aug 10, 202614w ago Insider Cluster Neutral 2/10 Entry $7.04 to $5.06 Now $5.00 −28.98% ▼ −28.13% −27.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers